Literature DB >> 2269669

Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure.

W S Argraves1, H Tran, W H Burgess, K Dickerson.   

Abstract

We have studied the expression of fibulin in cultured fibroblasts and determined its primary structure by cDNA cloning. Our results show that fibulin is a secreted glycoprotein that becomes incorporated into a fibrillar extracellular matrix when expressed by cultured cells or added exogenously to cell monolayers. In addition, we find that fibulin is present in plasma at a level of 33 +/- 3 micrograms/ml. Sequencing of multiple fibulin cDNAs indicates that a process of alternative splicing results in the expression of three fibulin transcripts. The transcripts encode overlapping polypeptides differing only in carboxy-terminal segments. Common to the three predicted forms of fibulin is a unique 537-amino acid-long cysteine-rich polypeptide and a 29-residue signal peptide. The amino-terminal portion of fibulin contains a repeated element with potential disulfide loop structure resembling that of the complement component anaphylatoxins C3a, C4a, and C5a as well as proteins of the albumin gene family. The bulk of the remaining portion of the molecule is a series of nine EGF-like repeats.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2269669      PMCID: PMC2116371          DOI: 10.1083/jcb.111.6.3155

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  31 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.

Authors:  H Lehrach; D Diamond; J M Wozney; H Boedtker
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

3.  Radioimmunoassay of alpha-fetoprotein with polyclonal and monoclonal antibodies.

Authors:  E Ruoslahti; M Uotila; E Engvall
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

4.  Efficient isolation of genes by using antibody probes.

Authors:  R A Young; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

5.  Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins.

Authors:  J Scott; M Urdea; M Quiroga; R Sanchez-Pescador; N Fong; M Selby; W J Rutter; G I Bell
Journal:  Science       Date:  1983-07-15       Impact factor: 47.728

6.  Isolation of microgram quantities of proteins from polyacrylamide gels for amino acid sequence analysis.

Authors:  M W Hunkapiller; E Lujan; F Ostrander; L E Hood
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  Structure of vitamin D-dependent calcium-binding protein from bovine intestine.

Authors:  D M Szebenyi; S K Obendorf; K Moffat
Journal:  Nature       Date:  1981-11-26       Impact factor: 49.962

8.  Surface distribution of LETS protein in relation to the cytoskeleton of normal and transformed cells.

Authors:  V Mautner; R O Hynes
Journal:  J Cell Biol       Date:  1977-12       Impact factor: 10.539

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Distribution of fetal bovine serum fibronectin and endogenous rat cell fibronectin in extracellular matrix.

Authors:  E G Hayman; E Ruoslahti
Journal:  J Cell Biol       Date:  1979-10       Impact factor: 10.539

View more
  59 in total

Review 1.  Fibulins: physiological and disease perspectives.

Authors:  W Scott Argraves; Lisa M Greene; Marion A Cooley; William M Gallagher
Journal:  EMBO Rep       Date:  2003-12       Impact factor: 8.807

2.  Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity.

Authors:  Ming Yi; Takao Sakai; Reinhard Fassler; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

3.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-03-11       Impact factor: 16.971

4.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-06-25       Impact factor: 16.971

5.  Hemicentin 2 and Fibulin 1 are required for epidermal-dermal junction formation and fin mesenchymal cell migration during zebrafish development.

Authors:  Natália Martins Feitosa; Jinli Zhang; Thomas J Carney; Manuel Metzger; Vladimir Korzh; Wilhelm Bloch; Matthias Hammerschmidt
Journal:  Dev Biol       Date:  2012-07-06       Impact factor: 3.582

6.  Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases.

Authors:  Gang Liu; Marion A Cooley; Andrew G Jarnicki; Alan C-Y Hsu; Prema M Nair; Tatt Jhong Haw; Michael Fricker; Shaan L Gellatly; Richard Y Kim; Mark D Inman; Gavin Tjin; Peter A B Wark; Marjorie M Walker; Jay C Horvat; Brian G Oliver; W Scott Argraves; Darryl A Knight; Janette K Burgess; Philip M Hansbro
Journal:  JCI Insight       Date:  2016-06-16

7.  Proteolytic cleavage of versican during cardiac cushion morphogenesis.

Authors:  Christine B Kern; Waleed O Twal; Corey H Mjaatvedt; Sarah E Fairey; Bryan P Toole; M Luisa Iruela-Arispe; W Scott Argraves
Journal:  Dev Dyn       Date:  2006-08       Impact factor: 3.780

8.  A novel intracellular fibulin-1D variant binds to the cytoplasmic domain of integrin beta 1 subunit.

Authors:  Waleed O Twal; Samar M Hammad; Sharon L Guffy; William S Argraves
Journal:  Matrix Biol       Date:  2015-02-03       Impact factor: 11.583

9.  Utilizing spectral counting to quantitatively characterize tandem removal of abundant proteins (TRAP) in human plasma.

Authors:  Christopher M Shuford; Adam M Hawkridge; John C Burnett; David C Muddiman
Journal:  Anal Chem       Date:  2010-11-19       Impact factor: 6.986

10.  Autoantibodies to tumor-associated antigens in breast carcinoma.

Authors:  Ettie Piura; Benjamin Piura
Journal:  J Oncol       Date:  2010-11-21       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.